Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Oct 30, 2009

NEW YORK (GenomeWeb News) – Caris Diagnostics has named Jerry Martino senior VP and CFO. He formerly was executive VP and COO for Par Pharmaceutical, and he was VP of global materials management and global supply chain operations for Schering-Plough.

Sequenom has appointed Paul Maier to begin serving as its interim CFO in November. He has worked as senior VP and CFO of Ligand Pharmaceuticals, where he helped build the company from its venture stage through raising more than $1 billion in equity and debt financings. He also worked at ICN Pharmaceuticals for six years in various management and finance positions.

Boston Biocom has appointed Michael Brownstein and John Parrish to its scientific advisory board. Brownstein recently was director of Functional Genomics at the J. Craig Venter Institute, and he has held several positions at the National Institutes of Mental Health. Parrish is founder of the Center for Innovative Medicine and Innovative Technology, and he was chairman of the Harvard Medical School's Department of Dermatology, as well as founder of the Wellman Center for Photomedicine.

Former Phoenix Mayor Skip Rimsza will work with the Translational Genomics Research Institute's TGen Foundation as head of the Foundation's Legacy Society. Rimsza was mayor of the city between 1994 and 2004, and he was involved in the effort to get TGen to locate in Arizona in 2002. In his role with TGen, Rimsza will develop opportunities and activities for the legacy society.

Heather Hampel has been re-elected as president of the American Board of Genetic Counseling. Hampel is a genetic counselor at The Ohio State University Comprehensive Cancer Center, and she represents the center on the National Comprehensive Cancer Network's Genetic/Familial High-Risk Assessment Panel.

The European Personalized Medicine Diagnostics Association, a new non-profit focused on promoting personalized medicine, has named its board of directors.

The board includes: Patrick Terry, founder of Genomic Health and the Personalized Medicine Coalition and CEO of Technic Solutions; Maria Aspinall, president and CEO of On-Q-ity, and former president of Genzyme Genetics; Vincent Fert, president and CEO of Ipsogen; Iain Miller, senior director of oncology strategy and theranositcs at BioMerieux; Herman Spolders, CEO of Oncomethylome Sciences; Werner Kroll, head of diagnostics research and innovation at Novartis Molecular Diagnostics; and Alain Huirez, chairman and CEO of TcLand Expression.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.